BEC partners with Takeda Pharmaceuticals

26 Oct, 2022

Buckman Enochs Coss and Associates is thrilled to announce our partnership with Takeda Pharmaceuticals to assist with the expansion of their commercial sales division. As a global leader of plasma-derived therapies, Takeda aligns with our deeply-rooted goals of accelerating the development of vital therapies in the Life Sciences field.

Takeda brilliantly combines their rich 240-year-old history and Japanese heritage with cutting-edge innovation, developing plasma-derived therapies that have saved thousands of lives around the world. Their admirable and unwavering commitment to patients of the rare and complex disease community drives their success as a top 25 pharmaceutical company nation-wide. We are committed to expanding Takeda’s sales division with top-performing, game-changing candidates.

Follow us on LinkedIn!